A novel combination of Genomics & AI for accurate, fast and affordable screening of genetic disorders / rare diseases.
We have developed a proprietary method for high-throughput and cost-effective genotyping. By calculating fractions of reads, our screening tool can identify chromosomal aberrations, deletions, insertions, tandem repeats, gene mutations, and hence recognise genetic disorders.
We harness the full power of analytics and Artificial Intelligence throughout the complete sequencing process. By using machine learning algorithms, our proprietary technology translates real-time data into accurate and meaningful results.
We use advanced encryption algorithms and techniques to protect data from unauthorized access, while ensuring fast and efficient encryption process. All data are secure by using Cryptography and Hashing, producing a structure of data with inherent security qualities.
At gMendel®, we want to make sure that all our products, services and processes meet our customers’ needs. This is why we have defined a robust quality management system (QMS) and a risk management process, conforming to ISO 13485 and ISO 14971, respectively.
The name gMendel® pays homage to Gregor Mendel, the pioneer of modern genetics. The prefix “g” not only signifies genetics and genomics but also embodies the concepts of “genius” and “genuine,” while its form is reminiscent of the DNA double helix, symbolizing the fundamental essence of life.
We have lived and worked across the globe, in Africa, Asia, South America, North America and Europe, and experienced healthcare systems that are diverse, often under-resourced, and full of contrast.
We also share a deep belief in the power of science and technology, and the power of working across disciplines, to solve complex problems.
But more personally, each of us has someone in our family or close circle who has suffered from a misdiagnosis, or was never diagnosed at all, due to a genetic condition. The invaluable time spent with our daughters, sons, siblings, cousins, and close friends has bestowed upon us a profound understanding of the challenges families face and the lengthy process of turning new technologies into practical clinical solutions.
When you put all that together, the global perspective, the belief in innovation, and the personal motivation, you get gMendel®. You get what we have developed. And you get a sense of what we are here to achieve and we hope you can join us.
We aim to pioneer affordable and accurate mass screening for early diagnosis in prenatal and newborn care, alleviating the burden on countless families, and significantly reducing healthcare costs.
